Shannon James Samuel bought XLO

March 26, 2026 · Form 4 insider transaction

Shannon James Samuel bought 5,000 shares of Xilio Therapeutics, Inc. at $8.79 per share, a transaction worth $44.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
5,000
Price
$8.79
Total value
$44.0K
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 26, 2026
Filing dateMarch 30, 2026
Shares owned after10,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $8.6758 to $9.2499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.; The number of shares beneficially owned reflects the 1-for-14 reverse stock split effected March 13, 2026.

View the original Form 4 on SEC EDGAR